Skincare company Obagi Medical has launched its CLENZIDERM M.D. Resurfacing Multi-Acid Peel Pads, available through aesthetic distributor Healthxchange.
Designed for normal-to-oily and combination skin, the pads target blemishes, discoloration, uneven tone and texture. The formula combines glycolic (4%), phytic (3%), salicylic (2%) and mandelic (1%) acids to resurface the skin, refine pores and improve the appearance of fine lines and discoloration, according to the company.
Obagi Medical share that the dual-sided lyocell textured pads offer customisable exfoliation, while niacinamide aims to reduce visible redness and support the skin barrier. The product is recommended for evening use two to three times weekly, or as tolerated, following cleansing.
Simone Shoffman, clinical and educational director at Healthxchange, commented, “The combination of four complementary acids provides a targeted approach to exfoliation, addressing multiple pathways associated with blemish-prone skin, while the clinical data demonstrates measurable improvements in texture, breakouts, brightness and pore appearance. It’s an exciting development for practitioners looking to support more comprehensive at-home skin management.”